Tag Archives: Cancer
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
By Chemistfrog:
With 2011 drawing to a close, biotech investors reflect on a year witnessing cataclysmic events such as the rise of Medivation (MDVN) from January’s $ 14 a share market cap of $ 489 million to Tuesday’s close of $ 41.65 and market cap of $ 1.45 billion as well as the demise of the mighty Dendreon (DNDN) falling from April’s $ 43 a share with a market cap $ 6.55 billion to Tuesday’s close of $ 7.21 with a market cap of $ 1.07 billion. Investing in the biotech industry has its rewards along with its risks. Entrances into MDVN or DNDN at the proper times along with wise exits would have reaped phenomenal rewards. However, gains would have been minimal for the former with devastating losses for the latter if long entrances and exits were improper.
Upcoming catalysts for three relatively unknown biotechs can lead to huge gains for investors with the savvy to open positions before
